Financial reports
NT 10-K
Notice of late annual filing
26 Mar 24
10-Q
2023 Q3
Quarterly report
17 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
13 Oct 23
10-Q
2023 Q1
Quarterly report
22 Sep 23
10-K
2022 FY
Annual report
1 Sep 23
NT 10-K
Notice of late annual filing
30 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
22 Aug 22
Current reports
8-K/A
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
22 Feb 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Entry into a Material Definitive Agreement
6 Dec 23
8-K
Changes in Registrant's Certifying Accountant
13 Nov 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Departure of Directors or Certain Officers
23 Jun 23
8-K
Regulation FD Disclosure
16 Feb 22
8-K
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
16 Jul 21
8-K
Entry into a Material Definitive Agreement
22 Jun 21
Registration and prospectus
424B3
Prospectus supplement
11 Aug 22
RW
Registration withdrawal request
9 Aug 22
S-1/A
IPO registration (amended)
9 Aug 22
S-1/A
IPO registration (amended)
8 Aug 22
S-1
IPO registration
2 Aug 22
424B3
Prospectus supplement
10 Jun 21
S-1/A
IPO registration (amended)
26 May 21
S-1
IPO registration
14 May 21
POS AM
Prospectus update (post-effective amendment)
3 May 21
POS AM
Prospectus update (post-effective amendment)
21 Apr 21
Proxies
DEF 14A
Definitive proxy
3 Oct 22
PRE 14A
Preliminary proxy
25 Aug 22
DEF 14A
Definitive proxy
29 Jun 20
DEF 14A
Definitive proxy
30 Apr 19
DEF 14C
Information statement
18 Dec 18
PRE 14C
Preliminary information
6 Dec 18
DEFA14A
Additional proxy soliciting materials
24 Aug 15
DEF 14A
Definitive proxy
17 Jul 15
DEF 14A
Definitive proxy
21 Nov 14
DEF 14A
Definitive proxy
9 Oct 14
Other
EFFECT
Notice of effectiveness
12 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
8 Aug 22
EFFECT
Notice of effectiveness
14 Jun 21
CORRESP
Correspondence with SEC
9 Jun 21
CORRESP
Correspondence with SEC
26 May 21
UPLOAD
Letter from SEC
24 May 21
EFFECT
Notice of effectiveness
5 May 21
CORRESP
Correspondence with SEC
28 Apr 21
UPLOAD
Letter from SEC
23 Apr 21
Ownership
3
Anthony Michael Panek
3 Oct 23
4
JAMES F SAMUELSON
26 Jun 20
4
Matthew Nicosia
19 Jun 20
3/A
Dominic Colvin
29 Apr 20
4
Dominic Colvin
29 Apr 20
3/A
Dominic Colvin
29 Apr 20
3
MARC R BRANSON
29 Apr 20
3
John Hamilton Cassels
4 Feb 20
3
Andrew Clifford Steedman
4 Feb 20
4/A
JAMES F SAMUELSON
3 Feb 20